SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-014204
Filing Date
2016-12-21
Accepted
2016-12-21 14:26:19
Documents
29
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gluc_10q.htm 10-Q 293800
2 CERTIFICATION gluc_ex311.htm EX-31.1 10948
3 CERTIFICATION gluc_ex321.htm EX-32.1 4153
  Complete submission text file 0001477932-16-014204.txt   1233006

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gluc-20160930.xml EX-101.INS 158956
5 XBRL TAXONOMY EXTENSION SCHEMA gluc-20160930.xsd EX-101.SCH 12858
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gluc-20160930_cal.xml EX-101.CAL 27890
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gluc-20160930_def.xml EX-101.DEF 7198
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gluc-20160930_lab.xml EX-101.LAB 94750
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gluc-20160930_pre.xml EX-101.PRE 69069
Mailing Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712
Business Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712 (888) 987-6315
Glucose Health, Inc. (Filer) CIK: 0001420108 (see all company filings)

IRS No.: 901117742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55439 | Film No.: 162063657
SIC: 2833 Medicinal Chemicals & Botanical Products